Animal Vaccines Market Size Worth $31.07 Billion By 2032 | CAGR: 9.90%

Animal Vaccines Market Size Worth $31.07 Billion By 2032 | CAGR: 9.90%

The global animal vaccines market size is expected to reach USD 31.07 billion by 2032, according to a new study by Polaris Market Research. The report “Animal Vaccines Market Share, Size, Trends, Industry Analysis Report, By Product (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines); By Type; By Disease; By Route of Administration; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic and zoonotic diseases in animals, as well as the growing focus on animal healthcare and immunization, are predicted to propel the expansion of the global market for animal vaccines. The market for animal vaccinations is restrained, nonetheless, by the high storage costs connected with vaccines and the strict regulatory requirements. The market for animal vaccinations is growing, however, since more medicines are being introduced to immunize various species.

The demand for livestock vaccines is increasing due to growing concerns regarding improved animal husbandry and food security. The production of livestock has increased global impact in increasing animal product demand. Also, the need for animal products has increased, including population expansion and changing lifestyles. These elements promote market expansion. The emergence of animal diseases and the ongoing release of vaccinations using cutting-edge technology have also contributed to the changing market dynamics.

In 2022, the market expanded modestly. Animal vaccines have been influenced by the COVID-19 pandemic, as with all other sectors. The OIE has said that no animals can spread this virus during the earliest stages of the pandemic. Yet, a few nations have recorded cases of human-to-animal transfer. IDEXX Labs and other businesses tested many dogs and cats for the virus, but the results were negative. In the early stages of the pandemic, there was concern that it would be transmitted by birds, which harmed the cattle sector.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:

Animal Vaccines Market Report Highlights

  • In 2022, the segment of attenuated live vaccines produced the highest revenue. This type of vaccine can elicit a wider range of immune responses, resulting in improved immunity compared to traditional vaccines.
  • The animal vaccines market was dominated by the subcutaneous segment in 2022. Injection sites for this type of vaccine are typically located in the neck and behind the shoulder blades of the animal. The ease of administering subcutaneous medications, which are gradually absorbed by the body, is expected to contribute to the market's growth.
  • In 2022, the ruminant vaccines segment was the market leader, generating the highest revenue. This dominance can be attributed to several factors, including an increase in livestock numbers, favorable government initiatives, and the emergence of diseases affecting cattle and sheep.
  • In 2022, North America was the dominant market and generated the highest revenue. This can be attributed to the region's higher incidence of livestock and zoonotic diseases, important to significant animal mortality and increased demand for animal vaccines.
  • During the forecast period, Asia Pacific is expected to be the fastest-growing region for the global market due to government initiatives in emerging economies and significant poultry, aquaculture, and pork industries in countries such as China.

Polaris Market Research has segmented the Animal Vaccines Market report based on product, type, disease, route of administration, and region:

Animal Vaccines Market, Products Outlook (Revenue - USD Billion, 2019 - 2032)

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Animal Vaccines Market, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Poultry
  • Aqua
  • Companion
    • Canine
    • Feline
  • Avian
  • Equine
  • Bovine

Animal Vaccines Market, Disease Outlook (Revenue - USD Billion, 2019- 2032)

  • Swine Pneumonia
  • Avian Influenza
  • Rabies
  • Coccidiosis
  • Brucellosis
  • Distemper
  • Canine
  • Foot & Mouth
  • Strangles

Animal Vaccines Market, Route of Administration Outlook (Revenue - USD Billion, 2019- 2032)

  • Subcutaneous
  • Intramuscular
  • Intranasal

Animal Vaccines Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa